Is Beyond Air Inc (XAIR) overvalued? · rev $7.7M
Beyond Air Inc (XAIR) is a medical devices company listed on US.
This page asks whether Beyond Air Inc (XAIR) looks expensive on cached numbers — not a short thesis.
Latest reported XAIR revenue for 2026-03-31 was $7.7M. Net income was -$33.2M. Revenue was up 107.3% from 2025-03-31 to 2026-03-31. XAIR currently screens at market cap $16.0M.
XAIR currently screens at market cap $16.0M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next XAIR 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the XAIR stock page for the full model, not this heading.
Not investment advice.